Clinical trials in Cyprus

A Phase II, Single-Arm, Open-Label Study Evaluating the Safety and Pharmacokinetics of the Intravenous Fixed‑Dose Combination (IV FDC) of Tiragolumab and Atezolizumab in Participants with Locally Advanced, Recurrent or Metastatic Solid Tumors

This study is testing a new combination of two drugs, tiragolumab and atezolizumab, for people with advanced solid tumours. It aims to see how safe the combination is and how the body handles these medicines.

HELIOS-A: A Phase 3 Global, Randomized, Open-label Study to Evaluate the Efficacy and Safety of ALN-TTRSC02 in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis)

This study is testing a new medicine, Amvuttra, for a rare inherited condition called hereditary transthyretin amyloidosis (hATTR amyloidosis). It aims to see if Amvuttra is safe and helps improve symptoms compared to standard treatments.

Lutetium-177-PSMA in Oligo-metastatic Hormone Sensitive Prostate Cancer.

This study is looking at a new treatment called Lutetium-177-PSMA for men with prostate cancer that hasn't spread widely and is sensitive to hormone therapy. It aims to see if this treatment can slow down the cancer's growth.

A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

This study looks at a new drug, efgartigimod PH20 SC, for adults with active idiopathic inflammatory myopathy (IIM), a condition causing muscle weakness and inflammation. It compares the drug to a dummy treatment to see if it helps improve muscle strength and overall well-being.

IMPact on Revascularization Outcomes of IVUS Guided Treatment of Complex Lesions and Economic Impact

This study compares two ways to guide heart stent procedures: standard X-rays or a more detailed ultrasound method. It aims to see if the detailed ultrasound improves results for people with complex heart blockages and is good value for money.

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry

This international study is gathering information on a very rare blood cancer called Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). It aims to understand the disease better, look at different treatments, and improve care by collecting data from patients worldwide.

The CROCO Study: CROhn's Disease COhort Study

The CROCO Study looks at how Crohn's disease changes over time in people getting the latest treatments. We hope to understand the disease better and find ways to predict its impact, ultimately improving care for patients.

SCAD : a Registry of Spontaneous Coronary Artery Dissection

This study is gathering information on a heart condition called Spontaneous Coronary Artery Dissection (SCAD). It's looking at how doctors currently diagnose and treat SCAD across Europe to learn more about it and improve care for patients.

A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

This study looks at a new medicine called efgartigimod for people with certain muscle conditions like myositis. It's for adults who were in a previous study, to see if the medicine is safe and helpful over a long time.

SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access

This study, called SPECTA, collects information and samples from cancer patients to help scientists better understand cancer. It aims to improve how we diagnose and treat different types of cancer in the future by looking at many different aspects of the disease.

The Next Step Towards the Elimination of Iodine Deficiency and Preventable Iodine-related Disorders in Europe

This study aims to teach young people in the UK and other countries about iodine deficiency and its health risks. It's an educational project in schools to help prevent problems caused by not getting enough iodine.

A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis

This study is testing a new medicine called efgartigimod for people with a type of Myasthenia Gravis (MG). It checks how well it works and if it's safe compared to a dummy medicine. Some people will then get the new medicine openly.

BPH Global Registry

This study is gathering information on men who are treated for an enlarged prostate (BPH) and related bladder symptoms. We want to understand what treatments are being used globally and how successful they are, to help improve care in the future.

A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis

This study looks at a new medicine for adults with a type of muscle weakness affecting the eyes called ocular myasthenia gravis. Researchers want to see if the medicine, Efgartigimod, is safe and helps improve eye symptoms. Some people will get the active medicine, and others will get a dummy treatment.

Validation of the European Oncology Quality of Life Toolkit

This study is testing a new set of online surveys called the EUonQoL-Kit. These surveys help understand the quality of life for people with cancer at different stages – during treatment, after treatment, and in palliative care. The goal is to make sure the surveys are accurate and helpful across Europe.

Efficacy of Ketamine for the Prevention of Relapse in Patients with Opioid-Use Disorders (OUD)

This study is looking into whether a medicine called ketamine can help people with opioid use disorder (addiction to strong painkillers or drugs like heroin) stay off opioids and reduce their cravings. It's an early-stage study to see how well it works.

A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo and Active-Controlled Phase III Therapeutic Superiority Trial Comparing the Efficacy and Tolerability of a Fixed-Dose Combination of Diclofenac potassium + Thiocolchicoside to Diclofenac potassium (Cataflam®) in Patients with Acute Severe Low Back Pain.

This study is looking at a new combination of two common pain medications, diclofenac potassium and thiocolchicoside, to see if it's better than diclofenac alone for severe back pain. Researchers are also checking for side effects.

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

This study looks at whether adding chemotherapy before surgery helps people with certain types of retroperitoneal sarcoma live longer without their cancer coming back. It compares surgery alone to chemotherapy followed by surgery.

A Multicenter, Adaptive, Randomized, Controlled Trial Platform to Evaluate Safety and Efficacy of Strategies and Treatments for Hospitalized Patients with Respiratory Infections: Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE) - Immune Modulation Strategy Trial